Clinical trials

7

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

High-intensity Interval Training Versus Moderate Intensity Continuous Training on Gut Microbiota in Non-alcoholic Fatty Liver

To compare High-Intensity Interval Training versus moderate intensity continuous training on gut microbiota in Non- Alcoholic Fatty Liver.

Participants needed: 60
Trial details
Age: 40-60Biological sex: AllType: InterventionalSponsor: Horus UniversityUpdated: Jul 13, 2026Locations: 1
Eligibility criteria

Patients from both genders aged 40 - 60 years old diagnosed with Non-alcoholic F... [+5]

History of liver cirrhosis or other chronic liver diseases. [+9]

Status: Recruiting

Desloratadine as Adjunct Therapy for Rheumatoid Arthritis

Rheumatoid arthritis is a chronic inflammatory disease that causes joint pain, swelling, and reduced physical function. Although standard disease-modifying antirheumatic drugs are effective for many patients, some individuals continue to have active disease. The purpose of this study is to evaluate the effectiveness and safety of adding desloratadine to standard therapy in patients with active rheumatoid arthritis. Participants will receive either desloratadine or placebo in addition to their usual treatment. The study will assess changes in disease activity and inflammatory markers over a follow-up period of approximately 12 weeks. The results of this study may help determine whether desloratadine could be a useful add-on treatment option for patients with rheumatoid arthritis.

Participants needed: 60
Trial details
Phase: Phase 2Age: 18-60Biological sex: AllType: InterventionalSponsor: Horus UniversityUpdated: Jun 8, 2026Locations: 1
Eligibility criteria

Patients with active rheumatoid arthritis according to the 2010 American College... [+5]

Patients with renal or hepatic disease. [+8]

Status: Recruiting

Effect of Roflumilast as Add-On Therapy in Rheumatoid Arthritis

Rheumatoid arthritis is a chronic inflammatory disease that causes joint pain, swelling, and reduced physical function. Although standard disease-modifying antirheumatic drugs are effective for many patients, some individuals continue to have active disease. The purpose of this study is to evaluate the effectiveness and safety of adding roflumilast to standard therapy in patients with active rheumatoid arthritis. Participants will receive either roflumilast or placebo in addition to their usual treatment. The study will assess changes in disease activity and inflammatory markers over a follow-up period of approximately 12 weeks. The results of this study may help determine whether roflumilast could be a useful add-on treatment option for patients with rheumatoid arthritis.

Participants needed: 50
Trial details
Phase: Phase 2Age: 18-60Biological sex: AllType: InterventionalSponsor: Horus UniversityUpdated: Jun 8, 2026Locations: 1
Eligibility criteria

Patients with active rheumatoid arthritis according to the 2010 American College... [+5]

Patients with renal or hepatic disease. [+8]

Status: Recruiting

Effect of Roflumilast and Desloratadine as Add-On Therapy in Patients With Rheumatoid Arthritis

Rheumatoid arthritis is a chronic inflammatory disease that causes joint pain, swelling, and disability. Although standard disease-modifying antirheumatic drugs (DMARDs) are effective for many patients, some individuals continue to experience active disease and inflammation. The aim of this study is to evaluate the effectiveness and safety of adding either roflumilast or desloratadine to standard DMARD therapy in patients with rheumatoid arthritis. Participants will be randomly assigned to receive either roflumilast, desloratadine, or placebo in addition to their usual treatment. The study will assess changes in disease activity, inflammatory biomarkers, and patient-reported outcomes over a three-month follow-up period. The results of this study may help identify new add-on treatment options to improve disease control in patients with rheumatoid arthritis.

Participants needed: 90
Trial details
Phase: Phase 2Age: 18-60Biological sex: AllType: InterventionalSponsor: Horus UniversityUpdated: May 12, 2026Locations: 1
Eligibility criteria

Patients with active rheumatoid arthritis according to the 2010 American College... [+4]

Patients with renal or hepatic disease. [+8]

Status: Recruiting

Liquid Phase Concentrated Growth Factor Versus Conventional Arthrocentesis in Temporomandibular Disc Displacement

This study aims to rigorously assess the effectiveness of LPCGF in the management of internal disc displacement in patients with TMD through a randomized clinical trial. By comparing LPCGF therapy with conventional arthrocentesis, this research looks to provide robust evidence on the efficacy, safety, and potential role of (LPCGF) as an alternative therapeutic choice for IDD.

Participants needed: 32
Trial details
Age: 18-45Biological sex: AllType: InterventionalSponsor: Horus UniversityUpdated: Mar 11, 2026Locations: 1
Eligibility criteria

1. Adults aged 18-45 years. 2. Patients scored as (ASA I).9 3. Presence of compl...

1. TMJ pathology related to mechanical deformities 2. Psychiatric problems or pr...

Status: Not yet recruiting

Demineralized Dentin Allograft Versus Demineralized Dentin Autograft for Socket Preservation

This study is designed to evaluate and compare clinically and radiographically the effectiveness of Demineralized Dentin Allograft (DDA) versus Demineralized Dentin Autograft (Auto-DD) for preservation of alveolar ridge dimensions after surgical extraction of the impacted mandibular third molar.

Participants needed: 40
Trial details
Age: 25-35Biological sex: AllType: InterventionalSponsor: Horus UniversityUpdated: Mar 11, 2026Locations: 1
Eligibility criteria

Patients aged between 25 to 35 years old. [+6]

1) Pregnant or lactating patients. 2) Relevant systemic diseases. 3) Patients wi...

Status: Recruiting

Validity and Reliability of the Egyptian-Arabic Version of ABILHAND-Kids

HYPOTHESES It is hypothesized that the Egyptian-Arabic ABILHAND-Kids 21-item will be psychometrically appropriate to be used with Egyptian children with cerebral palsy.

Participants needed: 100
Trial details
Age: 4-18Biological sex: AllType: ObservationalSponsor: Horus UniversityUpdated: Jul 11, 2024Locations: 1
Eligibility criteria

mental retardation